1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol has been researched along with Electrocardiogram QT Prolonged in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batey, AJ; Charman, WN; Coker, SJ; McIntosh, MP; Porter, CJ | 1 |
| Edwards, G; Gundersen, SG; Myrvang, B; Platou, ES; Rostrup, M; von der Lippe, E | 1 |
2 other study(ies) available for 1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Desbutylhalofantrine: evaluation of QT prolongation and other cardiovascular effects after intravenous administration in vivo.
Topics: Animals; Blood Pressure; Cardiovascular System; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Heart Rate; Infusions, Intravenous; Long QT Syndrome; Male; Phenanthrenes; Rabbits | 2003 |
Halofantrine-associated ventricular fibrillation in a young woman with no predisposing QTc prolongation.
Topics: Adult; Antimalarials; Female; Humans; Long QT Syndrome; Phenanthrenes; Ventricular Fibrillation | 1997 |